Dul Majid A: Screening of Antiangiogenic

Dul Majid A: Screening of Antiangiogenic PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/12711626 Activity of Some Tropical Plants by Rat Aorta Ring Assay. international Journal of Cancer 2009, 5(6):370-376. 14. Wang S, Zheng Z, Weng Y, Yu Y, Zhang D, Fan W, Dai R, Hu Z: Angiogenesis and anti-angiogenesis activity of Chinese medicinal herbal extracts. Life Sciences 2004, 74(20):2467-2478. 15. Sun DA, Starck SR, Locke EP, Hecht SM: DNA polymerase beta inhibitors from Sandoricum koetjape. J Nat Prod 1-phenyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole 1999, 62(8):1110-1113. 16. Muhammad I, El Sayed KA, Mossa JS, Al-Said MS, El-Feraly FS, Clark AM, Hufford CD, Oh S, Mayer AMS: Bioactive 12-Oleanene Triterpene and Secotriterpene Acids from Maytenus undata. Journal of Natural Products 2000, 63(5):605-610. 17. Rasadah MA, Khozirah S, Aznie AA, Nik MM: Anti-inflammatory agents from Sandoricum koetjape Merr. Phytomedicine 2004, 11(2-3):261-263. 18. Nassar ZD, Aisha AFA, Majid AMSA, Yeap CS, Fun HK: Koetjapic acid chloroform hemisolvate. Acta Crystallographica Section E 2010, 66(6): o1301-o1302. 19. Ferrara N: VEGF and the quest for tumour angiogenesis factors. Nat Rev Cancer n-Phenylpiperazine-1-carboxamide 2002, 2(10):795-803. 20. Paley PJ, Staskus KA, Gebhard K, Mohanraj D, Twiggs LB, Carson LF, Ramakrishnan S: Vascular endothelial growth factor expression in early stage ovarian carcinoma. Cancer 1997, 80(1):98-106. 21. Palmer RM, Ferrige AG, Moncada S: Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987, 327(6122):524-526. 22. Garg UC, Hassid A: Nitric oxide-generating vasodilators and 8-bromocyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 1989, 83(5):1774-1777. journal.pone.0167038 23. Cooke JP, Singer AH, Tsao P, Zera P, Rowan RA, Billingham ME: Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit. J Clin Invest PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/9638577 1992, 90(3):1168-1172.24. Janicek MJ, Meyerovitz M, Harrington DP, Hollenberg NK: Arterial response to ketanserin and aspirin in patients with advanced peripheral atherosclerosis. Invest Radiol 1992, 27(6):415-421. 25. Ku DD, Zaleski JK, Liu S, Brock TA: Vascular endothelial growth factor induces EDRF-dependent relaxation in coronary arteries. American Journal of Physiology - Heart and Circulatory Physiology 1993, 265(2): H586-H592. 26. van der Zee R, Murohara T, Luo Z, Zollmann F, Passeri J, Lekutat C, Isner JM: Vascular Endothelial Growth Factor/Vascular Permeability Factor Augments Nitric Oxide Release From Quiescent Rabbit and Human Vascular Endothelium. Circulation 1997, 95(4):1030-1037. 27. Murohara T, Horowitz JR, Silver M, Tsurumi Y, Chen D, Sullivan A, Isner JM: Vascular Endothelial Growth Factor/Vascular Permeability Factor Enhances Vascular Permeability Via Nitric Oxide and Prostacyclin. Circulation 1998, 97(1):99-107. 28. Morbidelli L, Chang CH, Douglas JG, Granger HJ, Ledda F, Ziche M: Nitric oxide mediates mitogenic effect of VEGF on coronary venular endothelium. Am J Physiol 1996, 270(1 Pt 2):H411-415. 29. Fan TP, Yeh JC, Leung KW, Yue PY, Wong RN: Angiogenesis: from plants to blood vessels. Trends Pharmacol Sci 2006, 27(6):297-309. 30. Yang S, Xin X, Zlot C, Ingle G, Fuh G, Li B, Moffat B, de Vos AM, Gerritsen ME: Vascular Endothelial Cell Growth Factor-Driven Endothelial Tube Formation Is Mediated by Vascular Endothelial Cell Growth Factor Receptor-2, a Kinase Insert Domain-Containing Receptor. Arterioscler Thromb Vasc Biol 2001, 21(12):1934-1940. 31. Mosmann T: Rapid colorimetric assay for cellular growth and survival:.